Mriglobal
- Assets
- $148.6m
- Revenue
- $119.6m
- Investments
- $0.0
- Employees
- 538
- Location
- Kansas City, MO
- Founding
- 07/1946
- Data as of
- 09/2023
- EIN
- 44-0545878
Organization Overview
Mriglobal is located in Kansas City, MO. The organization was established in 1946. According to its NTEE Classification (U20) the organization is classified as: General Science, under the broad grouping of Science & Technology and related organizations. As of 09/2023, Mriglobal employed 538 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Mriglobal is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2023, Mriglobal generated $119.6m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 4.5% each year. All expenses for the organization totaled $112.9m during the year ending 09/2023. While expenses have increased by 3.5% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Mriglobal has awarded 16 individual grants totaling $710,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
USE SCIENCE AND TECHNOLOGY TO CREATE SOLUTIONS FOR A SAFER, HEALTHIER, MORE SUSTAINABLE WORLD.
Describe the Organization's Program Activity:
SECURITY AND DEFENSE (S&D): S&D IS PRIMARILY INVOLVED IN RESEARCH AND DEVELOPMENT, ENGINEERING, AND PROGRAM MANAGEMENT IN THE AREAS OF COUNTERING WEAPONS OF MASS DESTRUCTION; CHEMICAL AND BIOLOGICAL AGENT AND EXPLOSIVE TEST, EVALUATION, AND ENGINEERING; MOBILE LABORATORY DESIGN, FABRICATION, DEPLOYMENT, STAFFING, AND SUPPORT; FORENSIC AND SOURCE ATTRIBUTION ANALYSIS, INDEPENDENT INSTRUMENTATION TEST AND EVALUATION; AND RAPID PROTOTYPING. S&D SUPPORTS FIELD MONITORING AND FORENSICS ANALYSIS PROGRAMS IN SUPPORT OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR, AND EXPLOSIVES (CBRNE) MISSIONS. PROJECTS FOCUSED ON THE DEVELOPMENT OF NATIONAL SECURITY SYSTEMS INCLUDE MOBILE LABORATORY ANALYTICAL SYSTEMS, CHEMICAL CONTAINMENT SYSTEMS, ROBOTICS SYSTEMS AND CHEMICAL SENSORS. THE U.S. GOVERNMENT FUNDS THE MAJORITY OF MRIGLOBAL'S S&D WORK.
GLOBAL HEALTH AND SECURITY (GHS): GHS CONDUCTS BIO-SURVEILLANCE, BIOSAFETY, AND BIOSECURITY PROGRAMS FOR THE U.S. GOVERNMENT. GHS'S WORK DEPENDS ON MRIGLOBAL'S ABILITY TO WORK WITH REGULATED SUBSTANCES REQUIRING HIGH LEVELS OF OVERSIGHT AND CERTIFICATION. GHS IS ALSO INVOLVED IN RESEARCH AND DEVELOPMENT IN PRODUCT DEVELOPMENT, REPOSITORY MANAGEMENT, DIAGNOSTICS, MEDICAL COUNTERMEASURES, PHARMACEUTICAL AND VACCINE DEVELOPMENT, AND AGRICULTURE AND FOOD SAFETY. THE LARGEST CLIENT SECTOR IS THE U.S. GOVERNMENT. GHS PERFORMS STUDIES THAT TARGET THE DEVELOPMENT OF THERAPEUTICS AND VACCINES UNDER FEDERALLY-MANDATED PREPARED PROGRAMS AND IN SUPPORT OF THE PHARMACEUTICAL INDUSTRY. GHS CONDUCTS ANALYSIS PROGRAMS FOR BIOLOGICAL PATHOGENS AND SUPPORTS TEST AND EVALUATION OF EMERGING BIOTECHNOLOGIES AND CLINICAL DIAGNOSTICS. GHS ALSO CONDUCTS PROGRAMS TO ASSESS AGRICULTURE PRODUCTS REQUIRING REGISTRATION UNDER EPA REQUIREMENTS. NIH-SPONSORED PROGRAMS FOR NIEHS AND NCI ARE AMONG GHS'S LARGEST CLIENTS. THE FOCUS OF THESE RESEARCH AND DEVELOPMENT PROGRAMS IS CHEMICAL CHARACTERIZATION, PREPARATION OF STUDY ARTICLES, AND REPOSITORY MANAGEMENT TO SUPPORT TOXICOLOGY AND PRE-CLINICAL STUDIES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Name Not Listed President And CEO - Incoming | OfficerTrustee | 40 | $573,720 |
Name Not Listed Director | Trustee | 1 | $47,500 |
Name Not Listed Director | Trustee | 1 | $45,000 |
Name Not Listed Director | Trustee | 1 | $42,500 |
Name Not Listed Director | Trustee | 1 | $52,500 |
Name Not Listed Director | Trustee | 1 | $47,500 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Draper Laboratory Research & Development | 9/29/23 | $2,493,778 |
Forgefx Research & Development | 9/29/23 | $2,293,056 |
Ohio State University Research & Development | 9/29/23 | $1,929,336 |
Conductive Technologies Research & Development | 9/29/23 | $1,790,055 |
Domenix Corporation Research & Development | 9/29/23 | $1,854,010 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $74,681,553 |
| All other contributions, gifts, grants, and similar amounts not included above | $133,262 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $74,814,815 |
| Total Program Service Revenue | $43,278,539 |
| Investment income | $1,435,390 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $94,627 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $119,632,626 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $45,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $4,556,690 |
| Compensation of current officers, directors, key employees. | $4,222,923 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $36,789,646 |
| Pension plan accruals and contributions | $3,986,434 |
| Other employee benefits | $4,413,330 |
| Payroll taxes | $2,940,970 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $291,605 |
| Fees for services: Accounting | $147,534 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $16,317 |
| Fees for services: Other | $8,245,953 |
| Advertising and promotion | $0 |
| Office expenses | $2,818,447 |
| Information technology | $956,463 |
| Royalties | $0 |
| Occupancy | $5,488,956 |
| Travel | $1,220,964 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $370,170 |
| Interest | $283,012 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $4,723,800 |
| Insurance | $441,326 |
| All other expenses | $787,096 |
| Total functional expenses | $112,859,972 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $44,236,804 |
| Pledges and grants receivable | $1,731,226 |
| Accounts receivable, net | $11,729,331 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $926,546 |
| Prepaid expenses and deferred charges | $1,846,967 |
| Net Land, buildings, and equipment | $47,595,792 |
| Investments—publicly traded securities | $8,973,576 |
| Investments—other securities | $0 |
| Investments—program-related | $2,434,537 |
| Intangible assets | $0 |
| Other assets | $29,153,644 |
| Total assets | $148,628,423 |
| Accounts payable and accrued expenses | $12,998,767 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $9,470,711 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $421,051 |
| Unsecured mortgages and notes payable | $3,092,592 |
| Other liabilities | $19,862,637 |
| Total liabilities | $45,845,758 |
| Net assets without donor restrictions | $97,502,954 |
| Net assets with donor restrictions | $5,279,711 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $148,628,423 |
Grants Awarded
Over the last fiscal year, Mriglobal has awarded $95,000 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
BIONEXUS KC PURPOSE: FOSTER SCIENTIFIC EDUCATION, INNOVATION & GROWTH | $50,000 |
UNION STATION KANSAS CITY INC PURPOSE: Foster scientific education | $45,000 |